Selling Shares of Waters Corporation [WAT]
BDX recently completed the separation of its Biosciences & Diagnostic Solutions business, which is now combined with an existing publicly traded company, Waters Corporation [WAT]. For every share of BDX held at the close of business on 2026-02-05, shareholders received .135 shares of WAT and cash in lieu of partial shares after market close on 2026-02-09. The Royal Dividends portfolio received 2 shares and $83.06 in cash. Using a market order those two shares were sold for $328.0729 per share. The $739.21 in total proceeds will be treated as dividend income received from BDX for performance purposes.
…



